Skip to main content
Clinical Trials/NCT03003507
NCT03003507CompletedPhase 4

Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients: A Cross-over Randomized Clinical Trial

Hospital Moinhos de Vento0 sites25 target enrollmentStarted: October 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
25
Primary Endpoint
Glycemic Variability

Study Overview

Brief Summary

Hyperglycemia is a known risk factor for mortality in critically ill patients. Most of these patients receive enteral feeding. There is controversy about ideal carbohydrate composition of these diets. The aim of this study was to compare an enteral formula with the same proportion of carbohydrates with and without fructose on blood glucose levels.

Detailed Description

Randomized, cross-over, controlled, double-blind clinical trial without washout. Adult patients admitted to the ICU who presented capillary glycemia values> 180mg / dl with a full and exclusive enteral diet. They were randomized and observed for 4 days (2 days with each diet: with / without fructose). Capillary glycemia was measured 4 / 4h.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Critical Illness
  • •Exclusive enteral diet
  • •Enteral diet with full nutritional value
  • •Hyperglycemia ≥180 mg / dl

Exclusion Criteria

  • •Oral feeding
  • •NPT (Total or Partial Parenteral Nutrition)
  • •Patient without indication of use of study diets

Arms & Interventions

Diet 1

Active Comparator

Low-carbohydrate Enteral Formula With Fructose

Intervention: Enteral Formula With Fructose (Dietary Supplement)

Diet 2

Active Comparator

Low-carbohydrate Enteral Formula Without Fructose

Intervention: Enteral Formula Without Fructose (Dietary Supplement)

Outcomes

Primary Outcomes

Glycemic Variability

Time Frame: four days

To evaluate the glycemic oscillation during the use of enteral feedings

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Magali Kumbier

Nutritionist

Hospital Moinhos de Vento

Similar Trials